Identification of micro-RNA networks in end-stage heart failure because of dilated cardiomyopathy

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 9, 2013, Pages 1173-1187

  Zhu, Xiaoming ^a   Wang, Hongjiang ^a   Liu, Fan ^b   Chen, Li ^c,d   Luo, Weijia ^d   Su, Pixiong ^a   Li, Weiming ^a   Yu, Liping ^a   Yang, Xinchun ^a   Cai, Jun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

^c TEXAS HEART INSTITUTE   (United States)

^d University of Houston   (United States)

Author keywords

Heart failure; MicroRNAs; Network

Indexed keywords

RATTUS;

MICRORNA;

ADULT; ANIMAL; ARTICLE; CELL CULTURE; CONFOCAL MICROSCOPY; CONGESTIVE CARDIOMYOPATHY; FEMALE; GENE ONTOLOGY; GENE REGULATORY NETWORK; GENETIC TRANSFECTION; GENETICS; HEART FAILURE; HEART MUSCLE CELL; HUMAN; LENTIVIRINAE; MALE; METABOLISM; MIDDLE AGED; NETWORK; PATHOLOGY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; VIROLOGY;

HEART FAILURE; MICRORNAS; NETWORK;

ADULT; ANIMALS; CARDIOMYOPATHY, DILATED; CELLS, CULTURED; FEMALE; GENE ONTOLOGY; GENE REGULATORY NETWORKS; HEART FAILURE; HUMANS; LENTIVIRUS; MALE; MICRORNAS; MICROSCOPY, CONFOCAL; MIDDLE AGED; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84884818765     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12096     Document Type: Article

References (42)

1. Kratlian RG, Hajjar RJ. Cardiac gene therapy: from concept to reality. Curr Heart Fail Rep. 2012; 9: 33-9.
2. Kaminsky LA, Arena R, Beckie TM, et al. The importance of cardiorespiratory fitness in the United States: the need for a national registry: a policy statement from the American Heart Association. Circulation. 2013; 127: 657-62.
3. Lin D, Hollander Z, Meredith A, et al. Molecular signatures of end-stage heart failure. J Card Fail. 2011; 17: 867-74.
4. Hogeweg P. The roots of bioinformatics in theoretical biology. PLoS Comput Biol. 2011; 7: e1002021.
5. Movassagh M, Choy MK, Knowles DA, et al. Distinct epigenomic features in end-stage failing human hearts. Circulation. 2011; 124: 2411-22.
6. Topkara VK, Mann DL. Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc Drugs Ther. 2011; 25: 171-82.
7. Friedman JM, Jones PA. MicroRNAs: critical mediators of differentiation, development and disease. Swiss Med Wkly. 2009; 139: 466-72.
8. Han M, Toli J, Abdellatif M. MicroRNAs in the cardiovascular system. Curr Opin Cardiol. 2011; 26: 181-9.
9. Mukhopadhyay P, Brock G, Appana S, et al. MicroRNA gene expression signatures in the developing neural tube. Birth Defects Res A Clin Mol Teratol. 2011; 91: 744-62.
10. Dorn GW 2nd. MicroRNAs in cardiac disease. Transl Res. 2011; 157: 226-35.
11. Sonkoly E, Pivarcsi A. Advances in microRNAs: implications for immunity and inflammatory diseases. J Cell Mol Med. 2009; 13: 24-38.
12. Xu J, Zhu X, Wu L, et al. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/beta-catenin pathway. Liver Int. 2012; 32: 752-60.
13. Dumortier O, Van Obberghen E. MicroRNAs in pancreas development. Diabetes Obes Metab. 2012; 14(Suppl. 3): 22-8.
14. Hinton A, Hunter S, Reyes G, et al. From pluripotency to islets: miRNAs as critical regulators of human cellular differentiation. Adv Genet. 2012; 79: 1-34.
15. Ouyang L, Shi Z, Zhao S, et al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012; 45: 487-98.
16. Ambros V. The functions of animal microRNAs. Nature. 2004; 431: 350-5.
17. Torrado M, Iglesias R, Centeno A, et al. Targeted gene-silencing reveals the functional significance of myocardin signaling in the failing heart. PLoS ONE. 2011; 6: e26392.
18. Gladka MM, da Costa Martins PA, De Windt LJ. Small changes can make a big difference - microRNA regulation of cardiac hypertrophy. J Mol Cell Cardiol. 2012; 52: 74-82.
19. Chen JF, Murchison EP, Tang R, et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci USA. 2008; 105: 2111-6.
20. Matkovich SJ, Van Booven DJ, Youker KA, et al. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation. 2009; 119: 1263-71.
21. Subramanyam D, Blelloch R. From microRNAs to targets: pathway discovery in cell fate transitions. Curr Opin Genet Dev. 2011; 21: 498-503.
22. Watanabe Y, Kanai A. Systems biology reveals microRNA-mediated gene regulation. Front Genet. 2011; 2: 29.
23. Ma MQ, Zhang K, Wang HY, et al. ELB-Q: a new method for improving the robustness in DNA microarray image quantification. IEEE Trans Inf Technol Biomed. 2007; 11: 574-82.
24. Binder H, Preibisch S, Berger H. Calibration of microarray gene-expression data. Methods Mol Biol. 2010; 576: 375-407.
25. Berezikov E, van Tetering G, Verheul M, et al. Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis. Genome Res. 2006; 16: 1289-98.
26. Zeitouni B, Boeva V, Janoueix-Lerosey I, et al. SVDetect: a tool to identify genomic structural variations from paired-end and mate-pair sequencing data. Bioinformatics. 2010; 26: 1895-6.
27. Maass AH, Buvoli M. Cardiomyocyte preparation, culture, and gene transfer. Methods Mol Biol. 2007; 366: 321-30.
28. Yang J, Chen Y. Fast computing betweenness centrality with virtual nodes on large sparse networks. PLoS ONE. 2011; 6: e22557.
29. van Almen GC, Verhesen W, van Leeuwen RE, et al. MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell. 2011; 10: 769-79.
30. Montgomery RL, Hullinger TG, Semus HM, et al. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation. 2011; 124: 1537-47.
31. Kotlo KU, Hesabi B, Danziger RS. Implication of microRNAs in atrial natriuretic peptide and nitric oxide signaling in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2011; 301: C929-37.
32. Wang J, Song Y, Zhang Y, et al. Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice. Cell Res. 2012; 22: 516-27.
33. Ono K, Kuwabara Y, Han J. MicroRNAs and cardiovascular diseases. FEBS J. 2011; 278: 1619-33.
34. Ikeda S, Kong SW, Lu J, et al. Altered microRNA expression in human heart disease. Physiol Genomics. 2007; 31: 367-73.
35. van Almen GC, Verhesen W, van Leeuwen RE, et al. MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell. 2011; 10: 769-79.
36. Androulidaki A, Iliopoulos D, Arranz A, et al. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity. 2009; 31: 220-31.
37. Faherty N, Curran SP, O'Donovan H, et al. CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGFbeta type II receptor with implications for nephropathic cell phenotypes. J Cell Sci. 2012; 125: 5621-9.
38. Taby R, Issa JP. Cancer epigenetics. CA Cancer J Clin. 2010; 60: 376-92.
39. Abbas A, Grant PJ, Kearney MT. Role of IGF-1 in glucose regulation and cardiovascular disease. Expert Rev Cardiovasc Ther. 2008; 6: 1135-49.
40. Grothey A, Voigt W, Schober C, et al. The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors. J Cancer Res Clin Oncol. 1999; 125: 166-73.
41. Baserga R, Peruzzi F, Reiss K. The IGF-1 receptor in cancer biology. Int J Cancer. 2003; 107: 873-7.
42. Werner H, Le Roith D. New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia. Cell Mol Life Sci. 2000; 57: 932-42.